Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Jardiance: Fournier’s Gangrene Standard For Criteria

What it is

We have previously discussed what type of injury that Fournier’s gangrene is, please see the link here. This blog is to clarify the qualifying standard that is currently required due to the August 2018 label change issued by the FDA when they determined that SGLT2 inhibitors could be linked to the Fournier’s gangrene injuries.[1]

Injury Information

As previously stated in our blog, the signature injury in this case is Fournier’s gangrene. Fournier’s gangrene is the necrosis of body tissue, particularly in the genitalia, perineum, or colorectal areas from an infection.[2] It is most commonly associated with the graying or blackening of skin due to the infection area and the type of necrotic tissue. It is extremely dangerous and even fatal if left untreated. Additionally, males are 10 times more likely to develop Fournier’s gangrene than females.[3]

Standard Criteria

The current standard for qualifying in the Jardiance Fournier’s Gangrene litigation is that (1) a person must’ve been injured after the consumption of Jardiance, and (2) the person that is injured must have begun taking Jardiance prior to the warning label changing in 2018, which would be prior to the August 2018 FDA warning.[4]

Call the Professionals

If you or a loved one have been injured by taking this drug, and you took the drug prior to the label change of August 29, 2018, please give us a call at 888-585-5970. The attorneys here at the Michael Brady Lynch Firm are the best at litigating pharmaceutical drug and device cases.

[1] https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrences-serious-infection-genital-area-sglt2-inhibitors-diabetes

[2] https://www.urologists.org/article/conditions/fourniers-gangrene

[3] https://www.urologists.org/article/conditions/fourniers-gangrene

[4] https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrences-serious-infection-genital-area-sglt2-inhibitors-diabetes

Update on The New Maryland Child Sexual Abuse Law

Update on The New Maryland Child Sexual Abuse Law

Maryland recently made a landmark change to its legal landscape by eliminating the civil statute of limitations for child sexual abuse cases under the **Child Victims Act of 2023**. This law, upheld by the Maryland Supreme Court in February 2025, allows survivors to file lawsuits regardless of how much time has passed since the abuse occurred.

read more
PIP Insurance Coverage Florida: How it Works

PIP Insurance Coverage Florida: How it Works

Florida is one of 12 “no-fault” insurance states, requiring drivers to carry Personal Injury Protection (PIP) insurance on vehicles operated in the state. PIP insurance allows injured drivers to receive compensation for damages and medical expenses by utilizing their insurance coverage.

read more
An Update on PFAS Cases: New Contamination Sites in US

An Update on PFAS Cases: New Contamination Sites in US

Per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” have been a growing concern due to their persistence in the environment and potential health risks. Recent developments have highlighted new contamination sites and legal actions aimed at addressing these issues across the United States.

read more
Nursing Home Abuse: An Overview

Nursing Home Abuse: An Overview

Nursing home abuse involves the mistreatment, neglect, or exploitation of residents in long-term care facilities. This includes skilled nursing homes, assisted living facilities, and other institutions responsible for the care of elderly or vulnerable adults. Under both federal and state laws, these facilities are required to provide residents with a safe, dignified, and compassionate environment.

read more
Oxbryta Recall: What You Need to Know

Oxbryta Recall: What You Need to Know

Oxbryta is a prescription medication developed to help people with sickle cell disease (SCD). It works by improving the oxygen-carrying ability of red blood cells and reducing the complications that come with SCD, like pain crises and organ damage. While it’s been seen as a breakthrough for managing this condition, a recent recall has raised serious concerns about its safety.

read more
Wegovy Lawsuits and Media Attention Increase

Wegovy Lawsuits and Media Attention Increase

Wegovy is a concentrated form of semaglutide, a GLP-1 receptor drug approved by the FDA to manage type 2 diabetes and weight loss. Wegovy is similar to Ozempic and manufactured by the same drug company, Novo Nordisk. As we’ve reported recently, patients who suffered from gastroparesis and blindness after taking Ozempic are filing cases against the drug’s manufacturer.

read more
Depo-Provera Lawsuits: Do You Have a Case?

Depo-Provera Lawsuits: Do You Have a Case?

Depo-Provera is an injectable birth control that has been popular among women as an effective method to prevent pregnancy without having to take daily birth control pills. However, recent studies have indicated a link between Depo-Provera use and serious diseases like brain tumors, meningioma, and osteoporosis. We are now taking Depo-Provera lawsuit cases and will help you get the compensation you deserve for your injuries due to extended Depo-Provera use.

read more
×
What Our Clients Are Saying